US20040231909A1 - Motorized vehicle having forward and backward differential structure - Google Patents

Motorized vehicle having forward and backward differential structure Download PDF

Info

Publication number
US20040231909A1
US20040231909A1 US10/440,861 US44086103A US2004231909A1 US 20040231909 A1 US20040231909 A1 US 20040231909A1 US 44086103 A US44086103 A US 44086103A US 2004231909 A1 US2004231909 A1 US 2004231909A1
Authority
US
United States
Prior art keywords
motorized vehicle
propeller shaft
thrust bearings
direction thrust
bearing seat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/440,861
Inventor
Tai-Yang Luh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TAIWAN POWER INDUSTRIAL Co Ltd
Original Assignee
TAIWAN POWER INDUSTRIAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32771871&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20040231909(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by TAIWAN POWER INDUSTRIAL Co Ltd filed Critical TAIWAN POWER INDUSTRIAL Co Ltd
Assigned to TAIWAN POWER INDUSTRIAL CO., LTD. reassignment TAIWAN POWER INDUSTRIAL CO., LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LUH, TAI-YANG
Publication of US20040231909A1 publication Critical patent/US20040231909A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Abstract

A motorized vehicle includes a plurality of single-direction thrust bearings mounted between each of the two rear wheels and the propeller shaft. The single-direction thrust bearings located at one rear wheel is used to drive the motorized vehicle to move forward, and the single-direction thrust bearings located at the other rear wheel is used to drive the motorized vehicle to move backward. Thus, when the two rear wheels are subjected to a drag and cannot be rotated with the propeller shaft synchronously, the single-direction thrust bearings will idle, thereby producing a differential effect.

Description

    BACKGROUND OF THE INVENTION
  • 1. Field of the Invention [0001]
  • The present invention relates to a motorized vehicle, and more particularly to a motorized vehicle having a forward and backward differential structure. [0002]
  • 2. Description of the Related Art [0003]
  • A conventional motorized vehicle comprises a differential mounted on the transmission gear of the gear box. The differential consists of a bevel gear set. The power of the motor is reduced by the reduction mechanism. Then, the reduced power is transmitted by the transmission gear of the gear box and the bevel gear of the differential to the propeller shafts at the left and right sides, to drive and rotate the wheels at the left and right sides. When the motorized vehicle is turned, the turning diameter of the wheel at the inner side is shorter than that of the wheel at the outer side, so that the differential consisting of the bevel gear set is used to balance the difference of the rotation speed between the wheel at the inner side and the wheel at the outer side. [0004]
  • However, the conventional differential consisting of a bevel gear set has a complicated construction, thereby increasing costs of fabrication, and thereby causing inconvenience in assembly and maintenance. [0005]
    • SUMMARY OF THE INVENTION
  • The primary objective of the present invention is to provide a motorized vehicle having a forward and backward differential structure. [0006]
  • Another objective of the present invention is to provide a motorized vehicle, wherein when the two rear wheels are subjected to a drag or resistance and cannot be rotated with the propeller shaft synchronously, the single-direction thrust bearing will idle, thereby producing a differential effect. [0007]
  • A further objective of the present invention is to provide a motorized vehicle, wherein the single-direction thrust bearings located at one of the two rear wheels is used to drive the motorized vehicle to move forward, and the single-direction thrust bearings located between the other rear wheel is used to drive the motorized vehicle to move backward. [0008]
  • A further objective of the present invention is to provide a motorized vehicle having a differential structure which can replace the conventional differential consisting of a bevel gear set, thereby reducing costs of fabrication, and thereby simplifying the construction. [0009]
  • In accordance with the present invention, there is provided a motorized vehicle, comprising: [0010]
  • two rear wheels; [0011]
  • a propeller shaft mounted on the two rear wheels and having two ends; and [0012]
  • a plurality of single-direction thrust bearings mounted between each of the two rear wheels and the propeller shaft, wherein: [0013]
  • the single-direction thrust bearings located between one of the two rear wheels and a first end of the propeller shaft has a rotation direction opposite to a normal rotation direction of the propeller shaft to drive the motorized vehicle to move forward; and [0014]
  • the single-direction thrust bearings located between the other one of the two rear wheels and a second end of the propeller shaft has a rotation direction opposite to a reverse rotation direction of the propeller shaft to drive the motorized vehicle to move backward. [0015]
  • Further benefits and advantages of the present invention will become apparent after a careful reading of the detailed description with appropriate reference to the accompanying drawings.[0016]
    • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a partially exploded perspective view of a motorized vehicle in accordance with the preferred embodiment of the present invention; [0017]
  • FIG. 2 is a front plan cross-sectional assembly view of the motorized vehicle as shown in FIG. 1; [0018]
  • FIG. 3 is a top plan cross-sectional assembly view of the motorized vehicle as shown in FIG. 1; [0019]
  • FIG. 4 is a perspective assembly view of the differential structure of the motorized vehicle in accordance with the preferred embodiment of the present invention; [0020]
  • FIG. 5 is an exploded perspective view of the differential structure of the motorized vehicle in accordance with the preferred embodiment of the present invention; [0021]
  • FIG. 6 is a side plan cross-sectional view of the differential structure of the motorized vehicle as shown in FIG. 4; [0022]
  • FIG. 7 is a schematic top plan operational view showing the turning state of the motorized vehicle in accordance with the preferred embodiment of the present invention; [0023]
  • FIG. 8 is a side plan cross-sectional assembly view showing the normal transmission state of the motorized vehicle in accordance with the preferred embodiment of the present invention; and [0024]
  • FIG. 9 is a side plan cross-sectional assembly view showing the differential state of the motorized vehicle in accordance with the preferred embodiment of the present invention.[0025]
    • DETAILED DESCRIPTION OF THE INVENTION
  • Referring to the drawings and initially to FIGS. 1-6, a motorized [0026] vehicle 10 having a forward and backward differential structure in accordance with the preferred embodiment of the present invention has a rear portion provided with a propeller shaft 11 having two ends each provided with a catch flange 12, a keyway 13 (see FIG. 6), and an outer thread 14 (see FIG. 6).
  • Each of the two ends of the [0027] propeller shaft 11 is provided with a bearing cap 20, two single-direction thrust bearings 30, a bearing seat 40, and a fixing member 50.
  • The [0028] bearing seat 40 is formed with a plurality of screw bores 41. The bearing cap 20 is formed with a plurality of through holes 21. The motorized vehicle 10 further comprises a plurality of locking screws 22 each extended through a respective one of the through holes 21 and each screwed into a respective one of the screw bores 41, thereby fixing the bearing cap 20 on the bearing seat 40.
  • Each of the two single-[0029] direction thrust bearings 30 is mounted between the bearing seat 40 and the propeller shaft 11. Each of the two single-direction thrust bearings 30 has an inner race formed with an inner keyway 31.
  • The motorized [0030] vehicle 10 further comprises a first key 32 secured in the inner keyway 31 of each of the two single-direction thrust bearings 30 and the keyway 13 of the propeller shaft 11, so that each of the two single-direction thrust bearings 30 is combined with the propeller shaft 11.
  • Each of the two single-[0031] direction thrust bearings 30 has an outer race formed with an outer keyway 310. The bearing seat 40 has two sides each formed with a keyway 42. The motorized vehicle 10 further comprises two second keys 320 each secured in the outer keyway 310 of a respective one of the two single-direction thrust bearings 30 and the keyway 42 of the bearing seat 40, so that each of the two single-direction thrust bearings 30 is combined with the bearing seat 40.
  • One of the two single-[0032] direction thrust bearings 30 is rested on and limited by the catch flange 12 of the propeller shaft 11 and the bearing cap 20.
  • The [0033] fixing member 50 is secured on the propeller shaft 11 and is rested on the other one of the two single-direction thrust bearings 30. Preferably, the fixing member 50 is formed with an inner thread 51 screwed on the outer thread 14 of the propeller shaft 11, so that the fixing member 50 is fixed on the propeller shaft 11.
  • The [0034] bearing seat 40 has a periphery provided with a fixing board 43, and the motorized vehicle 10 further comprises two rear wheels 60 each secured on the fixing board 43 of the respective bearing seat 40.
  • The [0035] fixing board 43 of the bearing seat 40 is formed with a plurality of through holes 44. Each of the two rear wheels 60 is formed with a plurality of through holes 62. The motorized vehicle 10 further comprises a plurality of locking bolts 45 each extended through a respective one of the through holes 44 of the fixing board 43 of the bearing seat 40 and a respective one of the through holes 62 of the respective rear wheel 60, so that each of the two rear wheels 60 is fixed on the fixing board 43 of the respective bearing seat 40.
  • In addition, the two single-[0036] direction thrust bearings 30 located at a first end of the propeller shaft 11 has a rotation direction opposite to the normal rotation direction (when the motorized vehicle 10 is moved forward) of the propeller shaft 11 to drive the motorized vehicle 10 to move forward, while the two single-direction thrust bearings 30 located at a second end of the propeller shaft 11 has a rotation direction opposite to the reverse rotation direction (when the motorized vehicle 10 is moved backward) of the propeller shaft 11 to drive the motorized vehicle 10 to move backward.
  • In operation, referring to FIGS. 7-9 with reference to FIGS. 1-6, when the [0037] motorized vehicle 10 is turned around, the rear wheel 60 at the inner side cannot be rotated with the propeller shaft 11 synchronously. At this time, the single-direction thrust bearing 30 idles, thereby producing a differential effect, thereby reducing the turning diameter of the motorized vehicle 10, and thereby reducing wear of the rear wheels 60.
  • Accordingly, the single-direction thrust bearings located at one of the two rear wheels is used to drive the motorized vehicle to move forward, and the single-direction thrust bearings located between the other rear wheel is used to drive the motorized vehicle to move backward. Thus, when the two rear wheels are subjected to a drag or resistance and cannot be rotated with the propeller shaft synchronously, the single-direction thrust bearing will idle, thereby producing a differential effect. [0038]
  • In practice, the motorized vehicle is driven by the two rear wheels. For example, the single-direction thrust bearings located at the left rear wheel is used to drive the motorized vehicle to move forward. At this time, the single-direction thrust bearings located at the right rear wheel idles. On the contrary, the single-direction thrust bearings located at the right rear wheel is used to drive the motorized vehicle to move backward. At this time, the single-direction thrust bearings located at the left rear wheel idles. Thus, the single-direction thrust bearings mounted on the two rear wheels form a differential effect when the motorized vehicle is turned or driven on an abnormal road condition. [0039]
  • Although the invention has been explained in relation to its preferred embodiment(s) as mentioned above, it is to be understood that many other possible modifications and variations can be made without departing from the scope of the present invention. It is, therefore, contemplated that the appended claim or claims will cover such modifications and variations that fall within the true scope of the invention. [0040]

Claims (11)

What is claimed is:
1. A motorized vehicle, comprising:
two rear wheels;
a propeller shaft mounted on the two rear wheels and having two ends; and
a plurality of single-direction thrust bearings mounted between each of the two rear wheels and the propeller shaft, wherein:
the single-direction thrust bearings located between one of the two rear wheels and a first end of the propeller shaft has a rotation direction opposite to a normal rotation direction of the propeller shaft to drive the motorized vehicle to move forward; and
the single-direction thrust bearings located between the other one of the two rear wheels and a second end of the propeller shaft has a rotation direction opposite to a reverse rotation direction of the propeller shaft to drive the motorized vehicle to move backward.
2. The motorized vehicle in accordance with claim 1, wherein each of the two ends of the propeller shaft is provided with a bearing cap, two single-direction thrust bearings, a bearing seat, and a fixing member.
3. The motorized vehicle in accordance with claim 2, wherein the bearing seat is formed with a plurality of screw bores, the bearing cap is formed with a plurality of through holes, and the motorized vehicle further comprises a plurality of locking screws each extended through a respective one of the through holes and each screwed into a respective one of the screw bores, thereby fixing the bearing cap on the bearing seat.
4. The motorized vehicle in accordance with claim 2, wherein each of the two single-direction thrust bearings is mounted between the bearing seat and the propeller shaft.
5. The motorized vehicle in accordance with claim 2, wherein each of the two ends of the propeller shaft is formed with a keyway, each of the two single-direction thrust bearings has an inner race formed with an inner keyway, and the motorized vehicle further comprises a first key secured in the inner keyway of each of the two single-direction thrust bearings and the keyway of the propeller shaft, so that each of the two single-direction thrust bearings is combined with the propeller shaft.
6. The motorized vehicle in accordance with claim 2, wherein each of the two single-direction thrust bearings has an outer race formed with an outer keyway, the bearing seat has two sides each formed with a keyway, and the motorized vehicle further comprises two second keys each secured in the outer keyway of a respective one of the two single-direction thrust bearings and the keyway of the bearing seat, so that each of the two single-direction thrust bearings is combined with the bearing seat.
7. The motorized vehicle in accordance with claim 2, wherein each of the two ends of the propeller shaft is formed with a catch flange, one of the two single-direction thrust bearings is rested on and limited by the catch flange of the propeller shaft and the bearing cap.
8. The motorized vehicle in accordance with claim 7, wherein the fixing member is secured on the propeller shaft and is rested on the other one of the two single-direction thrust bearings.
9. The motorized vehicle in accordance with claim 2, wherein each of the two ends of the propeller shaft is formed with an outer thread, and the fixing member is formed with an inner thread screwed on the outer thread of the propeller shaft, so that the fixing member is fixed on the propeller shaft.
10. The motorized vehicle in accordance with claim 2, wherein the bearing seat has a periphery provided with a fixing board, and each of the two rear wheels is secured on the fixing board of the respective bearing seat.
11. The motorized vehicle in accordance with claim 10, wherein the fixing board of the bearing seat is formed with a plurality of through holes, each of the two rear wheels is formed with a plurality of through holes, and the motorized vehicle further comprises a plurality of locking bolts each extended through a respective one of the through holes of the fixing board of the bearing seat and a respective one of the through holes of the respective rear wheel, so that each of the two rear wheels is fixed on the fixing board of the respective bearing seat.
US10/440,861 2003-01-15 2003-05-19 Motorized vehicle having forward and backward differential structure Abandoned US20040231909A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44086103P 2003-01-15 2003-01-15

Publications (1)

Publication Number Publication Date
US20040231909A1 true US20040231909A1 (en) 2004-11-25

Family

ID=32771871

Family Applications (7)

Application Number Title Priority Date Filing Date
US10/440,861 Abandoned US20040231909A1 (en) 2003-01-15 2003-05-19 Motorized vehicle having forward and backward differential structure
US10/758,307 Active 2025-04-21 US7569345B2 (en) 2003-01-15 2004-01-14 Gene expression markers for breast cancer prognosis
US12/478,632 Active 2024-05-25 US8034565B2 (en) 2003-01-15 2009-06-04 Gene expression markers for breast cancer prognosis
US13/221,549 Expired - Lifetime US8206919B2 (en) 2003-01-15 2011-08-30 Gene expression markers for breast cancer prognosis
US13/473,526 Expired - Lifetime US8741605B2 (en) 2003-01-15 2012-05-16 Gene expression markers for breast cancer prognosis
US14/257,723 Active 2026-07-13 US9944990B2 (en) 2003-01-15 2014-04-21 Gene expression markers for breast cancer prognosis
US15/897,617 Active 2024-06-17 US11220715B2 (en) 2003-01-15 2018-02-15 Gene expression markers for breast cancer prognosis

Family Applications After (6)

Application Number Title Priority Date Filing Date
US10/758,307 Active 2025-04-21 US7569345B2 (en) 2003-01-15 2004-01-14 Gene expression markers for breast cancer prognosis
US12/478,632 Active 2024-05-25 US8034565B2 (en) 2003-01-15 2009-06-04 Gene expression markers for breast cancer prognosis
US13/221,549 Expired - Lifetime US8206919B2 (en) 2003-01-15 2011-08-30 Gene expression markers for breast cancer prognosis
US13/473,526 Expired - Lifetime US8741605B2 (en) 2003-01-15 2012-05-16 Gene expression markers for breast cancer prognosis
US14/257,723 Active 2026-07-13 US9944990B2 (en) 2003-01-15 2014-04-21 Gene expression markers for breast cancer prognosis
US15/897,617 Active 2024-06-17 US11220715B2 (en) 2003-01-15 2018-02-15 Gene expression markers for breast cancer prognosis

Country Status (11)

Country Link
US (7) US20040231909A1 (en)
EP (4) EP2230318A1 (en)
JP (1) JP4723472B2 (en)
AT (1) ATE470723T1 (en)
AU (2) AU2004205878B2 (en)
CA (5) CA3013889A1 (en)
DE (1) DE602004027600D1 (en)
DK (3) DK2230319T3 (en)
ES (3) ES2725892T3 (en)
HK (1) HK1148783A1 (en)
WO (1) WO2004065583A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103465779A (en) * 2013-09-17 2013-12-25 哈尔滨工程大学 Double-engine type omni-directional four-wheel drive traveling mechanism

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984522B2 (en) 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
US8044259B2 (en) 2000-08-03 2011-10-25 The Regents Of The University Of Michigan Determining the capability of a test compound to affect solid tumor stem cells
US20060062786A1 (en) * 2000-11-08 2006-03-23 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to TRAIL receptors
US20090226429A1 (en) * 2001-05-25 2009-09-10 Human Genome Sciences, Inc. Antibodies That Immunospecifically Bind to TRAIL Receptors
US7361341B2 (en) * 2001-05-25 2008-04-22 Human Genome Sciences, Inc. Methods of treating cancer using antibodies that immunospecifically bind to trail receptors
US20050214209A1 (en) * 2001-05-25 2005-09-29 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to TRAIL receptors
US7348003B2 (en) 2001-05-25 2008-03-25 Human Genome Sciences, Inc. Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors
US20050129616A1 (en) * 2001-05-25 2005-06-16 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to TRAIL receptors
US20030180296A1 (en) * 2001-12-20 2003-09-25 Theodora Salcedo Antibodies that immunospecifically bind to trail receptors
EP2258872B1 (en) * 2002-03-13 2013-08-14 Genomic Health, Inc. Gene expression profiling in biopsied tumor tissues
US20040231909A1 (en) 2003-01-15 2004-11-25 Tai-Yang Luh Motorized vehicle having forward and backward differential structure
CA3061769C (en) * 2003-06-24 2021-10-26 Genomic Health, Inc. Methods of predicting the likelihood of long-term survival of a human patient with node-negative, estrogen receptor (er) positive, invasive ductal breast cancer without the recurrence of breast cancer
WO2005008213A2 (en) 2003-07-10 2005-01-27 Genomic Health, Inc. Expression profile algorithm and test for cancer prognosis
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
US20050112622A1 (en) * 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
EP1737980A2 (en) 2004-04-09 2007-01-03 Fondazione IRCCS Istituto Nazionale dei Tumori Gene expression markers for predicting response to chemotherapy
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
US20100035240A1 (en) * 2004-08-10 2010-02-11 Cardiff Biologicals Limited Methods and kit for the prognosis of breast cancer
AU2005289756B2 (en) * 2004-09-22 2011-10-13 Tripath Imaging, Inc. Methods and computer program products for analysis and optimization of marker candidates for cancer prognosis
US8065093B2 (en) 2004-10-06 2011-11-22 Agency For Science, Technology, And Research Methods, systems, and compositions for classification, prognosis, and diagnosis of cancers
JP5020088B2 (en) * 2004-11-05 2012-09-05 ジェノミック ヘルス， インコーポレイテッド Predicting response to chemotherapy using gene expression markers
DK1815014T3 (en) * 2004-11-05 2012-06-18 Genomic Health Inc Molecular indicators of breast cancer prognosis and prediction of treatment response
ZA200704796B (en) * 2004-12-07 2008-11-26 Genentech Inc Selecting patients for therapy with a HER inhibitor
EP3698807A1 (en) 2005-01-21 2020-08-26 Genentech, Inc. Fixed dosing of her antibodies
AU2006216732C1 (en) * 2005-02-23 2017-07-20 Genentech, Inc. Extending time to disease progression or survival in cancer patients using a HER dimerization inhibitor
US20080275652A1 (en) * 2005-05-13 2008-11-06 Universite Libre De Bruxelles Gene-based algorithmic cancer prognosis
JP2006316040A (en) 2005-05-13 2006-11-24 Genentech Inc Herceptin(r) adjuvant treatment
US20070099209A1 (en) * 2005-06-13 2007-05-03 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
ATE520979T1 (en) * 2005-08-24 2011-09-15 Bristol Myers Squibb Co BIOMARRKERS AND METHODS FOR DETERMINING SENSITIVITY TO MODULATORS OF THE EGF (EPIDERMAL GROWTH FACTOR) RECEPTOR
JP5129149B2 (en) 2005-10-31 2013-01-23 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン Compositions and methods for treating and diagnosing cancer
US7662580B2 (en) 2005-11-10 2010-02-16 Aurelium Biopharma Inc. Tissue diagnostics for breast cancer
TW200731980A (en) * 2005-12-29 2007-09-01 Alcon Mfg Ltd RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis
WO2007123772A2 (en) * 2006-03-31 2007-11-01 Genomic Health, Inc. Genes involved in estrogen metabolism
ES2539042T3 (en) * 2006-06-02 2015-06-25 Glaxosmithkline Biologicals S.A. Identification procedure of whether a patient will respond to immunotherapy or not
WO2008063521A2 (en) * 2006-11-13 2008-05-29 The General Hospital Corporation Gene-based clinical scoring system
WO2008092002A2 (en) 2007-01-24 2008-07-31 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing pancreatic cancer
WO2008109440A2 (en) 2007-03-02 2008-09-12 Genentech, Inc. Predicting response to a her dimerisation inhibitor based on low her3 expression
BRPI0809366B8 (en) 2007-03-28 2021-05-25 Harvard College substantially alpha-helical polypeptide, method for manufacturing same, amino acid and pharmaceutical composition
WO2008150512A2 (en) * 2007-06-04 2008-12-11 University Of Louisville Research Foundation, Inc. Methods for identifying an increased likelihood of recurrence of breast cancer
US9551033B2 (en) * 2007-06-08 2017-01-24 Genentech, Inc. Gene expression markers of tumor resistance to HER2 inhibitor treatment
WO2008154249A2 (en) * 2007-06-08 2008-12-18 Genentech, Inc. Gene expression markers of tumor resistance to her2 inhibitor treatment
AU2008289148A1 (en) * 2007-08-16 2009-02-26 Aventis Inc. Gene expression markers of recurrence risk in cancer patients after chemotherapy
GB0720113D0 (en) * 2007-10-15 2007-11-28 Cambridge Cancer Diagnostics L Diagnostic, prognostic and predictive testing for cancer
WO2009067655A2 (en) * 2007-11-21 2009-05-28 University Of Florida Research Foundation, Inc. Methods of feature selection through local learning; breast and prostate cancer prognostic markers
EP2065475A1 (en) * 2007-11-30 2009-06-03 Siemens Healthcare Diagnostics GmbH Method for therapy prediction in tumors having irregularities in the expression of at least one VEGF ligand and/or at least one ErbB-receptor
US20110130296A1 (en) * 2008-03-14 2011-06-02 The Regents Of The University Of California Multi-gene classifiers and prognostic indicators for cancers
BRPI0812682A2 (en) 2008-06-16 2010-06-22 Genentech Inc metastatic breast cancer treatment
US10359425B2 (en) * 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
US20100221752A2 (en) * 2008-10-06 2010-09-02 Somalogic, Inc. Ovarian Cancer Biomarkers and Uses Thereof
WO2010045234A1 (en) * 2008-10-14 2010-04-22 University Of Louisville Research Foundation, Inc. Methods of optimizing treatment of estrogen-receptor positive breast cancers
GB0821787D0 (en) * 2008-12-01 2009-01-07 Univ Ulster A genomic-based method of stratifying breast cancer patients
US20120041274A1 (en) 2010-01-07 2012-02-16 Myriad Genetics, Incorporated Cancer biomarkers
US20120225789A1 (en) * 2009-05-29 2012-09-06 Baylor College Of Medicine Dna repair or brca1-like gene signature
JP5705836B2 (en) 2009-05-29 2015-04-22 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト Modulators for HER2 signaling in gastric cancer patients expressing HER2
US20100316639A1 (en) 2009-06-16 2010-12-16 Genentech, Inc. Biomarkers for igf-1r inhibitor therapy
EP2275569A1 (en) * 2009-07-17 2011-01-19 Centre Leon Berard ZNF217 a new prognostic and predictive biomarker of recurrent, invasive and metastatic phenotypes in cancer
GB0917457D0 (en) * 2009-10-06 2009-11-18 Glaxosmithkline Biolog Sa Method
DK2504451T3 (en) * 2009-11-23 2019-08-05 Genomic Health Inc Methods for predicting the clinical course of cancer
WO2011088137A2 (en) * 2010-01-12 2011-07-21 H. Lee Moffitt Cancer Center & Research Institute Bad pathway gene signature
US20130143753A1 (en) * 2010-03-01 2013-06-06 Adelbio Methods for predicting outcome of breast cancer, and/or risk of relapse, response or survival of a patient suffering therefrom
WO2011146568A1 (en) 2010-05-19 2011-11-24 Genentech, Inc. Predicting response to a her inhibitor
CA2804391A1 (en) 2010-07-07 2012-01-12 Myriad Genetics, Inc. Gene signatures for cancer prognosis
SG186953A1 (en) 2010-07-09 2013-02-28 Somalogic Inc Lung cancer biomarkers and uses thereof
CN106198980B (en) 2010-08-13 2018-09-07 私募蛋白质体公司 Cancer of pancreas biomarker and application thereof
US8859723B2 (en) 2010-08-13 2014-10-14 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
EP2611941A4 (en) 2010-08-30 2014-01-22 Myriad Genetics Inc Gene signatures for cancer diagnosis and prognosis
US10011876B2 (en) 2010-11-23 2018-07-03 Krisani Biosciences Pvt. Ltd Method and system for prognosis and treatment of diseases using portfolio of genes
WO2012109233A2 (en) * 2011-02-07 2012-08-16 Board Of Regents, The University Of Texas System Methods for predicting recurrence risk in breast cancer patients
CN108929375A (en) 2011-10-18 2018-12-04 爱勒让治疗公司 Peptidomimetic macrocyclic compound
WO2013070521A1 (en) * 2011-11-08 2013-05-16 Genomic Health, Inc. Method of predicting breast cancer prognosis
WO2013083810A1 (en) 2011-12-09 2013-06-13 F. Hoffmann-La Roche Ag Identification of non-responders to her2 inhibitors
US8987414B2 (en) 2012-02-15 2015-03-24 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
WO2013170174A1 (en) * 2012-05-10 2013-11-14 H. Lee Moffitt Cancer Center And Research Institute, Inc. Method of diagnosing, treating and determining progression and survival of cancer cells using bcl-2 antagonist of cell death (bad) pathway gene signature
WO2013188600A1 (en) 2012-06-12 2013-12-19 Washington University Copy number aberration driven endocrine response gene signature
JP6526563B2 (en) 2012-11-01 2019-06-05 エイルロン セラピューティクス，インコーポレイテッド Disubstituted amino acids and methods for their preparation and use
EP4190918A1 (en) 2012-11-16 2023-06-07 Myriad Genetics, Inc. Gene signatures for cancer prognosis
MX363188B (en) 2012-11-30 2019-03-13 Hoffmann La Roche Identification of patients in need of pd-l1 inhibitor cotherapy.
CA2896899A1 (en) 2013-01-18 2014-07-24 Ellis KLINE Selective glycosidase regimen for immune programming and treatment of cancer
WO2014124454A1 (en) 2013-02-11 2014-08-14 Katerina Gurova Use of facilitates chromatin transcription complex (fact) in cancer
CN103558382B (en) * 2013-10-28 2015-11-18 深圳市第二人民医院 The application of CCNE1 gene on detecting in bladder transitional cell carcinoma
CN103558383B (en) * 2013-10-28 2015-11-18 深圳市第二人民医院 The application of ALDH2 gene on detecting in bladder transitional cell carcinoma
KR20150088433A (en) 2014-01-24 2015-08-03 삼성전자주식회사 Biomarker TFF1 for predicting effect of a c-Met inhibitor
EP3623482A1 (en) 2014-05-13 2020-03-18 Myriad Genetics, Inc. Gene signatures for cancer prognosis
US10633710B2 (en) 2014-08-15 2020-04-28 Arizona Board Of Regents On Behalf Of The University Of Arizona Methods for characterizing cancer
SG10201902594QA (en) 2014-09-24 2019-04-29 Aileron Therapeutics Inc Peptidomimetic macrocycles and uses thereof
US10905739B2 (en) 2014-09-24 2021-02-02 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and formulations thereof
ES2833543T3 (en) 2014-10-24 2021-06-15 Koninklijke Philips Nv Evaluation of the activity of the TGF cell signaling pathway using mathematical models of target gene expression
CA2965217A1 (en) 2014-10-24 2016-04-28 Koninklijke Philips N.V. Medical prognosis and prediction of treatment response using multiple cellular signaling pathway activities
AU2015334842B2 (en) 2014-10-24 2022-02-17 Koninklijke Philips N.V. Medical prognosis and prediction of treatment response using multiple cellular signaling pathway activities
MX2017011834A (en) 2015-03-20 2018-04-11 Aileron Therapeutics Inc Peptidomimetic macrocycles and uses thereof.
EP3073268A1 (en) * 2015-03-27 2016-09-28 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Biomarker panel for diagnosing cancer
CN108138237B (en) 2015-08-14 2022-04-05 皇家飞利浦有限公司 Assessment of NFkB cell signaling pathway activity using mathematical modeling of target gene expression
CN107058523A (en) * 2017-03-21 2017-08-18 温州迪安医学检验所有限公司 A kind of genetic test primer of breast carcinoma recurring risk assessment 21 and its application
EP3461915A1 (en) 2017-10-02 2019-04-03 Koninklijke Philips N.V. Assessment of jak-stat1/2 cellular signaling pathway activity using mathematical modelling of target gene expression
EP3502279A1 (en) 2017-12-20 2019-06-26 Koninklijke Philips N.V. Assessment of mapk-ap 1 cellular signaling pathway activity using mathematical modelling of target gene expression
CN110045120A (en) * 2018-01-15 2019-07-23 长庚医疗财团法人基隆长庚纪念医院 Detect detection kit and its application of the concentration of WISP1 in biological sample in preparation for breast cancer screening and detecting recurrence
WO2020013355A1 (en) * 2018-07-10 2020-01-16 서울대학교산학협력단 Composition for predicting prognosis of malignant phyllodes tumor and kit comprising same
EP4013896A4 (en) * 2019-08-12 2023-09-20 Baylor College of Medicine Proteogenomic methods for diagnosing cancer
CN113862363A (en) * 2021-10-27 2021-12-31 中山大学附属第一医院 Application of immune related gene in kit and system for breast cancer prognosis
CN114480650A (en) * 2022-02-08 2022-05-13 深圳市陆为生物技术有限公司 Marker and model for predicting three-negative breast cancer clinical prognosis recurrence risk

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6378397B1 (en) * 2000-10-25 2002-04-30 Jenn Jianq Co., Ltd. Differential gearing device
US6655515B2 (en) * 2001-05-24 2003-12-02 Tecumseh Products Company Modular bi-directional overrunning wheel clutch

Family Cites Families (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1252046A (en) 1982-11-04 1989-04-04 Martin J. Cline Methods for oncogenic detection
USRE35491E (en) 1982-11-04 1997-04-08 The Regents Of The University Of California Methods and compositions for detecting human tumors
US4699877A (en) 1982-11-04 1987-10-13 The Regents Of The University Of California Methods and compositions for detecting human tumors
US7838216B1 (en) 1986-03-05 2010-11-23 The United States Of America, As Represented By The Department Of Health And Human Services Human gene related to but distinct from EGF receptor gene
US5015568A (en) 1986-07-09 1991-05-14 The Wistar Institute Diagnostic methods for detecting lymphomas in humans
US5202429A (en) 1986-07-09 1993-04-13 The Wistar Institute DNA molecules having human BCL-2 gene sequences
US4968603A (en) 1986-12-31 1990-11-06 The Regents Of The University Of California Determination of status in neoplastic disease
US5831066A (en) 1988-12-22 1998-11-03 The Trustees Of The University Of Pennsylvania Regulation of bcl-2 gene expression
US5922855A (en) * 1993-12-17 1999-07-13 Oregon Health Sciences University Mammalian DNA mismatch repair genes MLH1 and PMS1
US6037134A (en) * 1994-03-07 2000-03-14 New York University Medical Center Methods that detect compounds that disrupt receptor tyrosine kinase/GRB-7 complexes
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
US5858678A (en) 1994-08-02 1999-01-12 St. Louis University Apoptosis-regulating proteins
US5830753A (en) 1994-09-30 1998-11-03 Ludwig Institute For Cancer Research Isolated nucleic acid molecules coding for tumor rejection antigen precursor dage and uses thereof.
US6218529B1 (en) * 1995-07-31 2001-04-17 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
US5882864A (en) 1995-07-31 1999-03-16 Urocor Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
DE69635740T2 (en) 1995-12-18 2006-09-14 Sugen, Inc., South San Francisco DIAGNOSIS AND TREATMENT OF AURA-1 AND / OR AUR-2 ASSOCIATED DISEASES
US6716575B2 (en) 1995-12-18 2004-04-06 Sugen, Inc. Diagnosis and treatment of AUR1 and/or AUR2 related disorders
US5670325A (en) 1996-08-14 1997-09-23 Exact Laboratories, Inc. Method for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample
US5741650A (en) 1996-01-30 1998-04-21 Exact Laboratories, Inc. Methods for detecting colon cancer from stool samples
US5821082A (en) 1996-05-23 1998-10-13 St. Louis University Health Sciences Center Anti-proliferation domain of a human Bcl-2 and DNA encoding the same
US6143529A (en) 1996-08-14 2000-11-07 Exact Laboratories, Inc. Methods for improving sensitivity and specificity of screening assays
US5928870A (en) 1997-06-16 1999-07-27 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6146828A (en) 1996-08-14 2000-11-14 Exact Laboratories, Inc. Methods for detecting differences in RNA expression levels and uses therefor
US6100029A (en) 1996-08-14 2000-08-08 Exact Laboratories, Inc. Methods for the detection of chromosomal aberrations
US6020137A (en) 1996-08-14 2000-02-01 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6203993B1 (en) 1996-08-14 2001-03-20 Exact Science Corp. Methods for the detection of nucleic acids
US5952178A (en) 1996-08-14 1999-09-14 Exact Laboratories Methods for disease diagnosis from stool samples
US5861278A (en) 1996-11-01 1999-01-19 Genetics Institute, Inc. HNF3δ compositions
KR100645448B1 (en) 1996-11-20 2006-11-13 예일 유니버시티 Survivin, a protein that inhibit cellular apoptosis, and its modulation
US5830665A (en) 1997-03-03 1998-11-03 Exact Laboratories, Inc. Contiguous genomic sequence scanning
US6033893A (en) 1997-06-26 2000-03-07 Incyte Pharmaceuticals, Inc. Human cathepsin
WO1999002714A1 (en) 1997-07-07 1999-01-21 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
WO1999020752A1 (en) * 1997-10-21 1999-04-29 The University Court Of The University Of Glasgow JMY, A CO-ACTIVATOR FOR p300/CBP, NUCLEIC ACID ENCODING JMY AND USES THEREOF
CA2318789C (en) * 1998-02-25 2011-05-10 The United States Of America As Represented By The Secretary Department Of Health And Human Services Cellular arrays for rapid molecular profiling
US6020135A (en) 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
AU4158799A (en) 1998-06-06 1999-12-30 Genostic Pharma Limited Probes used for genetic filing
AU766544B2 (en) 1998-06-06 2003-10-16 Genostic Pharma Limited Probes used for genetic profiling
US6696558B2 (en) 1998-09-09 2004-02-24 The Burnham Institute Bag proteins and nucleic acid molecules encoding them
EP1115737A4 (en) 1998-09-23 2004-11-24 Cleveland Clinic Foundation Novel interferon stimulated and repressed genes
US9534254B1 (en) 1999-02-02 2017-01-03 Abbott Molecular Inc. Patient stratification for cancer therapy based on genomic DNA microarray analysis
US6251601B1 (en) 1999-02-02 2001-06-26 Vysis, Inc. Simultaneous measurement of gene expression and genomic abnormalities using nucleic acid microarrays
AU3246200A (en) 1999-02-25 2000-09-14 Boris Bilynsky Nucleic acid molecules associated with melanoma and thyroid tumors
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
US20020039764A1 (en) 1999-03-12 2002-04-04 Rosen Craig A. Nucleic, acids, proteins, and antibodies
US6960439B2 (en) 1999-06-28 2005-11-01 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
US6692916B2 (en) 1999-06-28 2004-02-17 Source Precision Medicine, Inc. Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
US6326148B1 (en) 1999-07-12 2001-12-04 The Regents Of The University Of California Detection of copy number changes in colon cancer
US6710170B2 (en) 1999-09-10 2004-03-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US6271002B1 (en) 1999-10-04 2001-08-07 Rosetta Inpharmatics, Inc. RNA amplification method
EP1218394A4 (en) 1999-10-06 2004-04-14 Univ California Differentially expressed genes associated with her-2/neu overexpression
EP2228446A1 (en) 1999-12-01 2010-09-15 Genentech, Inc. Secreted and transmembrane polypeptieds and nucleic acids encoding the same
US6750013B2 (en) 1999-12-02 2004-06-15 Protein Design Labs, Inc. Methods for detection and diagnosing of breast cancer
US6248535B1 (en) 1999-12-20 2001-06-19 University Of Southern California Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens
WO2001051664A2 (en) * 2000-01-12 2001-07-19 Dana-Farber Cancer Institute, Inc. Method of detecting and characterizing a neoplasm
WO2001051661A2 (en) 2000-01-13 2001-07-19 Amsterdam Support Diagnostics B.V. A universal nucleic acid amplification system for nucleic acids in a sample
US6322986B1 (en) 2000-01-18 2001-11-27 Albany Medical College Method for colorectal cancer prognosis and treatment selection
EP1257664A4 (en) 2000-01-28 2006-04-05 Althea Technologies Inc Methods for analysis of gene expression
CA2395398A1 (en) 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
AU4592601A (en) 2000-03-21 2001-10-03 Millennium Predictive Medicine Novel genes, compositions, kits, and method for identification, assessment, prevention, and therapy of ovarian cancer
AU2001251086A1 (en) 2000-03-31 2001-10-15 Sir Mortimer B. Davis Jewish General Hospital Microchip arrays of regulatory genes
WO2002000677A1 (en) 2000-06-07 2002-01-03 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
WO2002008461A2 (en) 2000-07-21 2002-01-31 Global Genomics Ab A METHOD AND AN ALGORITHM FOR mRNA EXPRESSION ANALYSIS
AU2001277202A1 (en) 2000-07-26 2002-02-05 Applied Genomics, Inc. Bstp-ras/rerg protein and related reagents and methods of use thereof
US7118853B2 (en) 2000-07-26 2006-10-10 Applied Genomics, Inc. Methods of classifying, diagnosing, stratifying and treating cancer patients and their tumors
AU2001278011A1 (en) 2000-07-26 2002-02-05 Applied Genomics, Inc. Bstp-ecg1 protein and related reagents and methods of use thereof
WO2002010436A2 (en) * 2000-07-28 2002-02-07 The Brigham And Women's Hospital, Inc. Prognostic classification of breast cancer
US7795232B1 (en) 2000-08-25 2010-09-14 Genta Incorporated Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
US6582919B2 (en) 2001-06-11 2003-06-24 Response Genetics, Inc. Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival rates
US6602670B2 (en) 2000-12-01 2003-08-05 Response Genetics, Inc. Method of determining a chemotherapeutic regimen based on ERCC1 expression
AU2002234799A1 (en) * 2000-12-08 2002-06-18 Ipsogen Gene expression profiling of primary breast carcinomas using arrays of candidate genes
AU2002255478A1 (en) 2001-01-10 2002-09-12 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
US7776518B2 (en) 2001-01-12 2010-08-17 Yale University Detection of survivin in the biological fluids of cancer patients
WO2002057787A2 (en) 2001-01-12 2002-07-25 Yale University Detection of survivin in the biological fluids of cancer patients
MXPA03006617A (en) 2001-01-24 2004-12-02 Protein Design Labs Inc Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer.
US20070015148A1 (en) 2001-01-25 2007-01-18 Orr Michael S Gene expression profiles in breast tissue
CN1554025A (en) 2001-03-12 2004-12-08 Īŵ���ɷ����޹�˾ Cell-based detection and differentiation of disease states
JP4222835B2 (en) * 2001-03-14 2009-02-12 株式会社Ｄｎａチップ研究所 Cancer prediction methods
US7514209B2 (en) 2001-06-18 2009-04-07 Rosetta Inpharmatics Llc Diagnosis and prognosis of breast cancer patients
WO2003011897A1 (en) 2001-07-27 2003-02-13 The Regents Of The University Of California Modulation of heregulin and her3 interaction
US6898531B2 (en) * 2001-09-05 2005-05-24 Perlegen Sciences, Inc. Algorithms for selection of primer pairs
WO2003029273A2 (en) 2001-09-28 2003-04-10 Whitehead Institute For Biomedical Research Classification of lung carcinomas using gene expression analysis
US6964850B2 (en) 2001-11-09 2005-11-15 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
US20030198972A1 (en) 2001-12-21 2003-10-23 Erlander Mark G. Grading of breast cancer
EP2258872B1 (en) 2002-03-13 2013-08-14 Genomic Health, Inc. Gene expression profiling in biopsied tumor tissues
EP1492871A2 (en) 2002-03-28 2005-01-05 QLT Inc. Cancer associated protein kinases and their uses
EP1365034A3 (en) 2002-05-21 2004-02-18 Bayer HealthCare AG Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasia
JP2006507841A (en) * 2002-11-14 2006-03-09 ダーマコン， インコーポレイテッド Functional and ultrafunctional siRNA
AU2004203749A1 (en) * 2003-01-06 2004-07-22 Wyeth Compositions and methods for diagnosing and treating colon cancers
US20040231909A1 (en) * 2003-01-15 2004-11-25 Tai-Yang Luh Motorized vehicle having forward and backward differential structure
PT1597391E (en) 2003-02-20 2008-12-19 Genomic Health Inc Use of intronic rna to measure gene expression
WO2004111603A2 (en) 2003-05-28 2004-12-23 Genomic Health, Inc. Gene expression markers for predicting response to chemotherapy
CA3061769C (en) * 2003-06-24 2021-10-26 Genomic Health, Inc. Methods of predicting the likelihood of long-term survival of a human patient with node-negative, estrogen receptor (er) positive, invasive ductal breast cancer without the recurrence of breast cancer
WO2005008213A2 (en) 2003-07-10 2005-01-27 Genomic Health, Inc. Expression profile algorithm and test for cancer prognosis
EP1737980A2 (en) 2004-04-09 2007-01-03 Fondazione IRCCS Istituto Nazionale dei Tumori Gene expression markers for predicting response to chemotherapy
DK1815014T3 (en) 2004-11-05 2012-06-18 Genomic Health Inc Molecular indicators of breast cancer prognosis and prediction of treatment response
JP5020088B2 (en) 2004-11-05 2012-09-05 ジェノミック ヘルス， インコーポレイテッド Predicting response to chemotherapy using gene expression markers
CA2620936A1 (en) 2005-09-01 2007-03-08 Precision Therapeutics, Inc. Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics
EP1777523A1 (en) 2005-10-19 2007-04-25 INSERM (Institut National de la Santé et de la Recherche Médicale) An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
WO2007123772A2 (en) 2006-03-31 2007-11-01 Genomic Health, Inc. Genes involved in estrogen metabolism
AU2008289148A1 (en) 2007-08-16 2009-02-26 Aventis Inc. Gene expression markers of recurrence risk in cancer patients after chemotherapy
DK2294215T3 (en) 2008-05-12 2013-04-22 Genomic Health Inc Tests to predict cancer patients' response to various chemotherapeutic treatment options
KR101759175B1 (en) 2009-07-02 2017-07-18 바스프 에스이 Co-agglomerated latex polymer dispersions and methods of preparing and using same
DK2504451T3 (en) 2009-11-23 2019-08-05 Genomic Health Inc Methods for predicting the clinical course of cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6378397B1 (en) * 2000-10-25 2002-04-30 Jenn Jianq Co., Ltd. Differential gearing device
US6655515B2 (en) * 2001-05-24 2003-12-02 Tecumseh Products Company Modular bi-directional overrunning wheel clutch

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103465779A (en) * 2013-09-17 2013-12-25 哈尔滨工程大学 Double-engine type omni-directional four-wheel drive traveling mechanism

Also Published As

Publication number Publication date
HK1148783A1 (en) 2011-09-16
CA3013889A1 (en) 2004-08-05
EP2230318A1 (en) 2010-09-22
US20140287421A1 (en) 2014-09-25
AU2009238287B2 (en) 2012-06-28
US11220715B2 (en) 2022-01-11
AU2009238287A1 (en) 2009-12-03
CA2513117A1 (en) 2004-08-05
JP2006516897A (en) 2006-07-13
EP3059322B1 (en) 2019-04-10
WO2004065583A2 (en) 2004-08-05
AU2004205878A8 (en) 2004-08-05
CA2513117C (en) 2014-02-25
EP1587957B1 (en) 2010-06-09
ATE470723T1 (en) 2010-06-15
AU2004205878A1 (en) 2004-08-05
EP1587957A2 (en) 2005-10-26
AU2004205878B2 (en) 2009-08-27
US20180230548A1 (en) 2018-08-16
US9944990B2 (en) 2018-04-17
CA2829476C (en) 2018-07-10
US8741605B2 (en) 2014-06-03
EP2230319A2 (en) 2010-09-22
CA2829477A1 (en) 2004-08-05
DK1587957T3 (en) 2010-09-27
EP3059322A1 (en) 2016-08-24
US20110312532A1 (en) 2011-12-22
US8034565B2 (en) 2011-10-11
CA2829477C (en) 2018-07-10
DK2230319T3 (en) 2016-01-25
US20120225433A1 (en) 2012-09-06
DK3059322T3 (en) 2019-05-06
ES2561179T3 (en) 2016-02-24
ES2346967T3 (en) 2010-10-22
EP2230319A3 (en) 2011-01-12
US20040209290A1 (en) 2004-10-21
CA2829476A1 (en) 2004-08-05
JP4723472B2 (en) 2011-07-13
CA2829472A1 (en) 2004-08-05
DE602004027600D1 (en) 2010-07-22
EP2230319B1 (en) 2015-10-21
US8206919B2 (en) 2012-06-26
US20100222229A1 (en) 2010-09-02
CA2829472C (en) 2018-08-14
WO2004065583A3 (en) 2005-03-03
US7569345B2 (en) 2009-08-04
ES2725892T3 (en) 2019-09-30

Similar Documents

Publication Publication Date Title
US20040231909A1 (en) Motorized vehicle having forward and backward differential structure
US20110120794A1 (en) Chain Gear, Vehicle Comprising a Chain Gear and Method for Transforming a motor Torque in a Vehicle
US20110303035A1 (en) Final drive for a work machine
EP0962349A2 (en) Power transmission device
US6080077A (en) Planetary gear drive train
JPWO2008053775A1 (en) Decelerator
SE504653C2 (en) Compact gearbox with large gear ratio
JPH10278813A (en) Electric power steering device
US20020130483A1 (en) Chainless transmission mechanism for bicycles
US20070290478A1 (en) Bicycle
DE60116571D1 (en) Twin wheels with differential
US6776737B2 (en) Planetary differential gear
KR200336799Y1 (en) Transmission mechanism with a single differential mechanism
JP4072234B2 (en) Clutch device
US20150246710A1 (en) Power module of electric bicycle
CN112154094A (en) Wheel drive module with a wheel accommodated therein
US5088969A (en) Bifurcated transmission drive
US20060270511A1 (en) Differential gear apparatus
EP1467125A2 (en) Planetary differential gear
US6561594B1 (en) Wheel shaft structure of monocycle
KR20080007295A (en) Boat
US6378397B1 (en) Differential gearing device
CN220320221U (en) Equal center distance transmission structure
US999876A (en) Worm-drive and compensating gearing.
US6318197B1 (en) Speed changeable gear drive apparatus for a wheeled vehicle

Legal Events

Date Code Title Description
AS Assignment

Owner name: TAIWAN POWER INDUSTRIAL CO., LTD., TAIWAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LUH, TAI-YANG;REEL/FRAME:014095/0612

Effective date: 20030505

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION